The alternatives to Gain.pro worth knowing are Inven, which produces company one-pagers and overview slides in your firm's own PowerPoint template from data Inven owns; PitchBook, for private-equity and venture deal history; Capital IQ, the filings and comps terminal most banks already run; Grata and SourceScrub, the middle-market coverage tools now both owned by Datasite; and Valu8, for Nordic and European registry financials. Which one is "best" depends on which job you were using Gain.pro for — and it is worth saying upfront that for Gain.pro's core job, analyst-reviewed financials on European private companies across roughly four million names, none of these is a straight swap. The alternatives win on the jobs around that one: producing the deliverable, covering deal history, running comps, or reaching companies Gain.pro does not track.

Which Gain.pro alternative fits which job?

Match the tool to the task: Inven if the output you need is the profile slide itself, PitchBook for deal history, Capital IQ for filings and comps, Grata or SourceScrub for middle-market coverage, and Valu8 for registry financials in the Nordics and Europe.

Is Inven a good alternative to Gain.pro?

Yes, if the thing you actually need at the end of the process is the page. Inven writes the one-pager or overview slide in your firm's own PowerPoint template — description, headcount, locations, deal history, and figures from filings, formatted the way your slides always look — from data Inven itself collects and maintains on more than 28 million companies (Inven product data, August 2026). Gain.pro gives you reviewed numbers; you still build the slide. Inven's output is the slide.

The dataset is Inven's own — it does not sit on top of PitchBook, Capital IQ, or FactSet — and at 28 million-plus companies it reaches well past Gain.pro's roughly four million, which matters when the target is small enough to fall outside Gain.pro's coverage. The setup works as a saved task: an analyst defines the template and fields once, and the team reruns it on every next company. The boundary, stated plainly: Inven can't yet make a full CDD deck, pitch book, CIM, or teaser, but it shines in the individual slides and analyses that are parts of them. To see it on your own template, book a demo.

What Inven is not is a like-for-like replacement for Gain.pro's analyst desk. If your work depends on a human-reviewed P&L for a German Mittelstand company, that is the job Gain.pro built its reputation on, and you should judge it on that job.

Can PitchBook or Capital IQ replace Gain.pro?

For parts of the work, yes; for the core of it, no. PitchBook is the deepest source for deal history — investors, rounds, valuations, sponsor activity — so if what you took from Gain.pro was ownership context, PitchBook covers that and goes further. Capital IQ is the terminal for filings and comps, and if your team's workflow already runs through its Excel plugin, reported figures and comp sets are its home ground.

What neither offers is Gain.pro's specific product: analyst-reviewed financials on European private companies. PitchBook's private-company financials are patchier and not reviewed to the same standard, and Capital IQ's coverage thins quickly below the mid-market in Europe. Treat these two as complements to Gain.pro rather than replacements for it.

Are Grata and SourceScrub alternatives to Gain.pro?

Only if your real need is coverage rather than financial depth. Grata builds its dataset from company websites, which gives it reach into middle-market companies the traditional databases miss; it has been part of Datasite since June 2025. SourceScrub takes a similar aim at US companies through conference lists and directories, was acquired by Datasite in August 2025, and is being folded into Grata — so over time these two are becoming one product.

Neither gives you what Gain.pro's analysts produce: reviewed financials on a specific European private company. If you were leaving Gain.pro because it did not cover the companies you care about, Grata is a reasonable direction, especially in the US middle market. If you were leaving over something else, coverage tools solve a different problem than the one you have.

What is the best alternative for Nordic or European registry financials?

Valu8. It draws on official registry filings across the Nordics and Europe, so the figures are the ones companies actually filed, on private companies that never appear in the global terminals. For a Stockholm or Helsinki fund working domestic and regional targets, it is often the most direct Gain.pro alternative on this list, because it competes on the same axis: real financials on private European companies.

The trade-off is scope. Valu8's strength is regional, and registry data is filed data — official, but without the analyst layer Gain.pro adds on top. Teams working across regions usually pair it with something broader.

Do I need to drop Gain.pro to use Inven?

No, and plenty of teams should not. The two do different jobs and run well together: Gain.pro remains the specialist when the work needs analyst-reviewed financials on a European private company, and Inven produces the one-pagers and overview slides in your firm's template from its own data — including the deal history and filed figures that belong on a profile page. One is a research depth decision; the other is a decision about how the deliverable gets made.

The practical way to decide what you need is to look at where your analysts' hours actually go. If the slow part is the financial diligence on European targets, keep Gain.pro at the center. If the slow part is turning company facts into presentable slides, twenty times a quarter, that is the specific problem Inven exists for — book a demo and compare its output against a one-pager your team recently made.